uniQure N.V.

uniQure N.V.verified

QURE

Price:

$27.57

Market Cap:

$1.74B

uniQure N.V. operates as a specialized gene therapy company, dedicated to pioneering therapeutic solutions for individuals grappling with severe genetic and other debilitating illnesses. The firm's most advanced project, Etranacogene dezaparvovec (designated as AMT-061), is currently progressing through a crucial Phase III pivotal trial, known as HOPE-B, targeting the treatment of hemophilia B. In addition to its flagship program, uniQure is actively developing several other candidates. This includes AMT-130, a gene therapy undergoing Phase I/II clinical assessment for Huntington's disease, and AMT-060, also in Phase I/II clinical trials for hemophilia B. The company's pipeline further exten...[Read more]

Industry

Biotechnology

IPO Date

2014-02-05

Stock Exchange

NASDAQ

Ticker

QURE

The Enterprise Value as of June 2026 (TTM) for uniQure N.V. (QURE) is 1.66B

According to uniQure N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.66B. This represents a change of 6.49% compared to the average of 1.56B of the last 4 quarters.

uniQure N.V. (QURE) Historical Enterprise Value (quarterly & annually)

How has QURE Enterprise Value performed in the past?

The mean historical Enterprise Value of uniQure N.V. over the last ten years is 956.59M. The current 1.66B Enterprise Value has changed 17.28% with respect to the historical average. Over the past ten years (40 quarters), QURE's Enterprise Value was at its highest in in the September 2025 quarter at 2.88B. The Enterprise Value was at its lowest in in the June 2016 quarter at 21.70M.

Quarterly (TTM)
Annual

Average

956.59M

Median

796.99M

Minimum

27.94M

Maximum

2.56B

uniQure N.V. (QURE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of uniQure N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.29%

Maximum Annual Enterprise Value = 2.56B

Minimum Annual Increase = -82.92%

Minimum Annual Enterprise Value = 27.94M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20251.83B139.13%
2024766.27M248.65%
2023219.78M-77.44%
2022974.36M82.73%
2021533.23M-62.79%
20201.43B-44.05%
20192.56B209.48%
2018827.71M112.55%
2017389.42M1.29%
201627.94M-82.92%

uniQure N.V. (QURE) Average Enterprise Value

How has QURE Enterprise Value performed in the past?

The current Enterprise Value of uniQure N.V. (QURE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

939.48M

5-year avg

865.20M

10-year avg

956.59M

uniQure N.V. (QURE) Enterprise Value vs. Peers

How is QURE’s Enterprise Value compared to its peers?

uniQure N.V.’s Enterprise Value is greater than Viridian Therapeutics, Inc. (1.35B), less than Structure Therapeutics Inc. (2.16B), less than Edgewise Therapeutics, Inc. (3.72B), greater than Ocular Therapeutix, Inc. (1.37B), greater than Galapagos N.V. (1.58B), less than Vera Therapeutics, Inc. (2.42B), greater than Nuvation Bio Inc. (1.59B), less than Celldex Therapeutics, Inc. (2.05B), less than Mesoblast Limited (1.79B), less than AbCellera Biologics Inc. (1.66B),

Build a custom stock screener for uniQure N.V. (QURE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like uniQure N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

uniQure N.V. (QURE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like uniQure N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is uniQure N.V.'s Enterprise Value?

What is the highest Enterprise Value for uniQure N.V. (QURE)?

What is the 3-year average Enterprise Value for uniQure N.V. (QURE)?

What is the 5-year average Enterprise Value for uniQure N.V. (QURE)?

How does the current Enterprise Value for uniQure N.V. (QURE) compare to its historical average?